ENDPOINTS

Biohaven gets an up to $600M investment; Prilenia, Ferrer make a deal in Europe

Plus, #AUA2025 news from Protara Therapeutics, Pfizer, CG Oncology, and UroGen, in addition to the latest updates from Spruce Biosciences and Rezolute: Biohaven’s up to $600M financing deal: The Connecticut drugmaker will get $250 million ...

Apr 28, 2025 - 16:00
 0
Biohaven gets an up to $600M investment; Prilenia, Ferrer make a deal in Europe
Plus, #AUA2025 news from Protara Therapeutics, Pfizer, CG Oncology, and UroGen, in addition to the latest updates from Spruce Biosciences and Rezolute: Biohaven’s up to $600M financing deal: The Connecticut drugmaker will get $250 million ...
Read More

Tags:

Previous Article

Daiichi Sankyo says production boost in US will help cushion tariff impact

Next Article

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

Related Posts

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

FDA asks Novavax for post-marketing data of its Covid v...

Apr 23, 2025  0

Bill cutting tax deductions for drug ads could help fund 'pill penalty' fix

Bill cutting tax deductions for drug ads could help fun...

Apr 28, 2025  0

Merck Q1 earnings: Gardasil sales hit by China market pressure

Merck Q1 earnings: Gardasil sales hit by China market p...

Apr 24, 2025  0